disease 5,291 words KG: ent-dise-06dd4f81
Contents

Alzheimer's Disease

Disease Info
Amyloid-beta plaquesExtracellular deposits of Aβ peptides (Aβ40, Aβ42)
Neurofibrillary tanglesIntracellular tau protein aggregates (paired helical filaments)
Neuronal lossProgressive death of synapses and neurons, particularly in hippocampus and cortex
Neuroinflammationchronic activation of microglia and astrocytes; the NF-κB Signaling pathway regulates this response
Synaptic dysfunctionEarly loss of synaptic markers and function
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (190)

TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
Microglial Purinergic Reprogramming
Score: 0.70
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro
Score: 0.64
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.61
Correcting Gut Microbial Dopamine Imbalance to Support Syste
Score: 0.61
Temporal Decoupling via Circadian Clock Reset
Score: 0.54
Cryptic Exon Silencing Restoration
Score: 0.53
Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption
Score: 0.47
← Prevpg 10/10

Related Analyses (30)

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzh
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · completed
Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · archived
Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived

Related Experiments (30)

CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.51
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
Lifestyle Intervention Mechanisms in Alzheimer's Disease
validation · proposed · Score: 0.40

See Also (15)

ASL Perfusion Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Digital Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
Dried Blood Spot Biomarker Test for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
DTI Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses
EEG Biomarkers for Alzheimer's Disease
biomarker · Pages share 18 hypotheses

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.